Pathological aspects of malignant and benign thymic disorders.

Pathological aspects of malignant and benign thymic disorders.

Item
http://www.wikidata.org/entity/Q33780539
Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravisIdentification of novel thymic epithelial cell subsets whose differentiation is regulated by RANKL and Traf6Immunological system status and the appearance of respiratory system disturbances in thymectomized patients.Recurrent genetic aberrations in thymoma and thymic carcinomaThymic epithelial tumors can develop along two different pathogenetic pathways.Chromosome 6 suffers frequent and multiple aberrations in thymoma.miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis.Expression and polymorphisms of T cell immunoglobulin domain and mucin domain protein-1 in thymoma with or without myasthenia gravis.Thymoma in myasthenia gravis: from diagnosis to treatment.
P2860

Pathological aspects of malignant and benign thymic disorders.

Item
http://www.wikidata.org/entity/Q33780539
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pathological aspects of malignant and benign thymic disorders.
@ast
Pathological aspects of malignant and benign thymic disorders.
@en
type
label
Pathological aspects of malignant and benign thymic disorders.
@ast
Pathological aspects of malignant and benign thymic disorders.
@en
prefLabel
Pathological aspects of malignant and benign thymic disorders.
@ast
Pathological aspects of malignant and benign thymic disorders.
@en
P1433
P1476
P2093
P304
P31
P407
P478
P577
P698
P1433
P1476
Pathological aspects of malignant and benign thymic disorders
@en
P2093
P304
P31
P407
P478
P577
P698